Non-Invasive Intracranial Pressure Monitoring Devices Market by Application and Geography - Forecast and Analysis 2022-2026

The non-invasive intracranial pressure monitoring devices market share is expected to increase by USD 125.89 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.02%.

This non-invasive intracranial pressure monitoring devices market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers non-invasive intracranial pressure monitoring devices market segmentations by application (traumatic brain injury, intracerebral hemorrhage, subarachnoid hemorrhage, meningitis, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The non-invasive intracranial pressure monitoring devices market report also offers information on several market vendors, including Compumedics Ltd., Integra LifeSciences Corp., Johnson and Johnson, Medtronic Plc, Natus Medical Inc., Nihon Kohden Corp., RAUMEDIC AG, Sophysa, and Spiegelberg GmbH and Co. KG among others.

What will the Non-Invasive Intracranial Pressure Monitoring Devices Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Non-Invasive Intracranial Pressure Monitoring Devices Market Size for the Forecast Period and Other Important Statistics

Non-Invasive Intracranial Pressure Monitoring Devices Market: Key Drivers, Trends, and Challenges

The growing awareness of non-invasive ICP monitoring devices is notably driving the non-invasive intracranial pressure monitoring devices market growth, although factors such as availability and use of invasive ICP monitoring devices may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the non-invasive intracranial pressure monitoring devices industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Non-Invasive Intracranial Pressure Monitoring Devices Market Driver

The growing awareness of non-invasive ICP monitoring devices is one of the key drivers supporting the non-invasive intracranial pressure monitoring devices market growth. For instance, in North America, the United States Brain Injury Alliance, Brain Injury Association of Canada, and Brain Injury Association of America are a few organizations that are working toward raising awareness about the prevention and management of brain injuries. These organizations also promote the use of non-invasive ICP monitoring devices. The presence of such organizations and associations helps in increasing awareness regarding brain injuries and provides support to hospitals and medical centers. These efforts are expected to enhance the growth of the global non-invasive ICP monitoring devices market during the forecast period.

Key Non-Invasive Intracranial Pressure Monitoring Devices Market Trend

Growing R and D activities and clinical studies is one of the key monitoring devices market trends that is contributing to the market growth. The growing adoption of non-invasive ICP devices led the governments in developed countries to provide funding to small-scale research and manufacturing companies to develop non-invasive ICP monitoring products. The funds are provided for conducting R and D of non-invasive ICP monitoring devices. For instance, the National Institutes of Health (NIH) provided the developmental grant to Carnegie-Mellon University in the US for a project on non-invasive ICP devices. The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is the administering institute for this project. In 2020, the total funding for the project was estimated to be $183,773. Such fundings are anticipated to boost the market growth during the forecast period.

Key Non-Invasive Intracranial Pressure Monitoring Devices Market Challenge

The availability and use of invasive ICP monitoring devices is one of the factors hindering the non-invasive intracranial pressure monitoring devices market growth. Advances in technology have expanded the use of invasive ICP monitoring devices in conjunction with other medical devices. For instance, Integra LifeSciences offers Camino Flex Ventricular Catheter in conjunction with the magnetic resonance imaging (MRI) scan under the 1.5 and 3 Tesla devices. Camino Flex ventricular catheter is used for ICP monitoring as well as for the management of CSF. All these developments have resulted in the increased adoption of invasive ICP monitoring devices. Thus, the availability of invasive ICP monitoring devices as a substitute will pose a threat for the market vendors. Such market challenges can negatively impact the growth of the global non-invasive ICP monitoring devices market during the forecast period.

This non-invasive intracranial pressure monitoring devices market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global non-invasive intracranial pressure (ICP) monitoring devices market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the non-invasive intracranial pressure monitoring devices market during the forecast period.

Who are the Major Non-Invasive Intracranial Pressure Monitoring Devices Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Compumedics Ltd.
• Integra LifeSciences Corp.
• Johnson and Johnson
• Medtronic Plc
• Natus Medical Inc.
• Nihon Kohden Corp.
• RAUMEDIC AG
• Sophysa
• Spiegelberg GmbH and Co. KG

This statistical study of the non-invasive intracranial pressure monitoring devices market encompasses successful business strategies deployed by the key vendors. The non-invasive intracranial pressure monitoring devices market is concentrated and the vendors are deploying growth strategies such as investing in the development of customized solutions to compete in the market.

Product Insights and News

• Compumedics Ltd. - Under the unified segment, the company is involved in the development, manufacture and commercialization of diagnostic technologies for the sleep, brain and ultrasonic blood flow monitoring applications. 
• Compumedics Ltd. - The company offers non-invasive intracranial pressure monitoring devices that include electrode arrays, ambulatory EEG monitoring, cEEG for ICU. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The non-invasive intracranial pressure monitoring devices market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Non-Invasive Intracranial Pressure Monitoring Devices Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the non-invasive intracranial pressure monitoring devices market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Non-Invasive Intracranial Pressure Monitoring Devices Market?

For more insights on the market share of various regions Request for a FREE sample now!

41% of the market's growth will originate from North America during the forecast period. The US is the key market for the non-invasive intracranial pressure monitoring devices market in North America. Market growth in this region will be slower than the growth of the market in Asia.

The presence of global key vendors will facilitate the non-invasive intracranial pressure monitoring devices market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the COVID-19 pandemic negatively impacted the regional non-invasive ICP monitoring devices market. However, in H2 2020, due to the introduction of vaccines, the number of COVID-19 cases decreased in the region. This led to the resumption of elective procedures in hospitals and other healthcare facilities. Such factors will drive the regional market during the forecast period.

What are the Revenue-generating Application Segments in the Non-Invasive Intracranial Pressure Monitoring Devices Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The non-invasive intracranial pressure monitoring devices market share growth by the traumatic brain injury segment will be significant during the forecast period. Traumatic brain injury, also known as an intracranial injury, is a form of acquired brain injury, which can result from a violent blow, bump, or jolt to the head. It can lead to permanent or temporary impairment of the physical, cognitive, and psychosocial functions of the injured person. TBI is considered one of the leading causes of disability and death in adults. According to the data provided by the Centers for Disease Control and Prevention (CDC), in the US, there were approximately 223,050 TBI-related hospitalizations in 2018 and 60,611 TBI-related deaths in 2019. Moreover, the growth of the TBI market segment can be attributed to the rising product launches by market vendors which measure ICP for medical conditions such as TBI.  Such factors are driving the segment growth.

This report provides an accurate prediction of the contribution of all the segments to the growth of the non-invasive intracranial pressure monitoring devices market size and actionable market insights on post COVID-19 impact on each segment.

Request for a FREE sample

What are the Key Data Covered in this Non-Invasive Intracranial Pressure Monitoring Devices Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive non-invasive intracranial pressure monitoring devices market growth during the next five years
• Precise estimation of the non-invasive intracranial pressure monitoring devices market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the non-invasive intracranial pressure monitoring devices industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of non-invasive intracranial pressure monitoring devices market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch